3B Blackbio (3BBLACKBIO) | Stock Overview & Key Data
3B Blackbio Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹2,350.00 on December 9, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| 3B Blackbio 3BBLACKBIO | 13.73B Small-cap | -4.74% | -7.68% | -13.86% | -18.42% | -22.82% | 36.12% | 92.56% | 92.56% |
| Biocon BIOCON | 492.92B Large-cap | -1.54% | 5.57% | 18.21% | 2.46% | 1.46% | 6.59% | 12.47% | -13.38% |
| OneSource Specialty ONESOURCE | 229.08B Large-cap | -2.08% | -3.51% | 31.77% | 15.75% | 15.75% | 16.96% | 16.96% | 16.96% |
| Dishman Carbogen DCAL | 40.61B Small-cap | -2.88% | -11.69% | 24.96% | 0.12% | -10.67% | 50.72% | 110.96% | 46.82% |
| Zota Health Care ZOTA | 33.34B Small-cap | 0.28% | 22.81% | 53.03% | 30.89% | 50.95% | 117.97% | 359.95% | 769.79% |
| Panacea Biotec PANACEABIO | 25.65B Small-cap | 1.41% | -9.56% | -7.89% | -0.90% | -5.31% | 202.30% | 225.73% | 152.79% |
Ownership & Short Interest
3B Blackbio Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in 3B Blackbio would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
What is 3BBLACKBIO's 52-week high and low?
In the last 52 weeks, 3B Blackbio reached a high of ₹2,350.00 (on December 11, 2024) and a low of ₹990.00 (on July 19, 2024).
What is the market cap and P/E ratio for 3BBLACKBIO?
Curious about 3B Blackbio's size and valuation? Its market capitalization stands at 13.73B. When it comes to valuation, the P/E ratio (trailing twelve months) is 28.74, and the forward P/E (looking ahead) is N/A.
Does 3BBLACKBIO pay dividends? If so, what's the yield?
As for dividends, 3B Blackbio isn't currently offering a significant yield, or that specific data isn't available right now.
Who are 3B Blackbio's main competitors or similar companies to consider before investing?
When looking at 3B Blackbio, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
| Company | Mkt Cap | Sector | Industry | 1Y Return | 3Y Return |
|---|---|---|---|---|---|
| Biocon BIOCON | 492.92B | Healthcare | Biotechnology | 6.59% | 12.47% |
| OneSource Specialty ONESOURCE | 229.08B | Healthcare | Biotechnology | 16.96% | 16.96% |
| Dishman Carbogen DCAL | 40.61B | Healthcare | Biotechnology | 50.72% | 110.96% |
| Zota Health Care ZOTA | 33.34B | Healthcare | Biotechnology | 117.97% | 359.95% |
| Panacea Biotec PANACEABIO | 25.65B | Healthcare | Biotechnology | 202.30% | 225.73% |
For a more comprehensive list, please see the Peer Performance Comparison table on this page.
What are the key financial health indicators for 3B Blackbio Diagnostics Ltd.? (e.g., ROE, Debt/Equity)
To get a sense of 3B Blackbio's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 19.21%, the Debt to Equity ratio from the most recent quarter is 0.11, and its Gross Profit Margin stands at 65.95%.
What is the recent revenue and earnings growth for 3BBLACKBIO?
Looking at 3B Blackbio's growth, its revenue over the trailing twelve months (TTM) was INR965M. Compared to the same quarter last year (YoY), quarterly revenue grew by -2.70%, and quarterly earnings saw a YoY growth of 2.00%.
How much of 3BBLACKBIO stock is held by insiders and institutions?
Wondering who owns 3B Blackbio stock? Company insiders (like executives and directors) hold about 64.95% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.74%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.